Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

That negative investor reaction was directed at companies involved in the white-hot weight loss drug segment of the market (Eli Lilly is the ... a “Double Down” stock recommendation for ...

If you wait for a top growth stock to come down to a P/E of 20 or less, you may end up waiting forever and missing out on the opportunity completely. For years, Eli Lilly has been generating solid ...

Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

or is Lilly stock still a buy? Let's find out. Image source: Getty Images. What's behind Lilly's double-digit revenue growth So, first let's talk about the Eli Lilly story so far. It's important ...

Eli Lilly (NYSE: LLY) stock has had plenty of good trading sessions over the past year or so, but Monday's sure wasn't among them. The storied pharmaceutical company's shares lost nearly 5% of ...

Approval for orforglipron would not only generate a lot of bullishness for the healthcare stock, but would also provide Eli Lilly with yet another blockbuster drug, and potentially enable it to ...

Now the question is: Is it too late to get in on this weight loss giant, or is Lilly stock still a buy? Let's find out. So, first let's talk about the Eli Lilly story so far. It's important to ...